Publications by authors named "Jochen Fleckenstein"

Claim this Profile
I
Intraoperative radiotherapy in elderly patients with breast cancer: long-term follow-up results of the prospective phase II trial TARGIT-E.
Elena Sperk, Claire Lemanski, Christian Neumaier, Juliane Lauer, Victor Siefert, Jochen Fleckenstein

BMC Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerated vs. conventionally fractionated postoperative radiotherapy of non-small cell lung cancer-final results of the prematurely terminated PORTAF trial.
Rebecca Bütof, Lydia Koi, Steffen Löck, Steffen Appold, Steffen Drewes, Jochen Fleckenstein

Strahlenther Onkol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reconsidering palliative radiotherapy in addition to PD-1 blockade for non-small cell lung cancer: results from the FORCE phase II trial (AIO/YMO-TRK-0415).
Farastuk Bozorgmehr, Inn Chung, Jürgen R Fischer, Marc Bischof, Akin Atmaca, Jochen Fleckenstein

Clin Exp Metastasis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metagenomic Profiling of Oral Microbiome Dynamics During Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma Patients.
Dominique A Torozan, Cédric Christian Laczny, Kirsten Roomp, Paul Wilmes, Jochen Fleckenstein

Cancer Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ArthroRad trial: randomized multicenter single-blinded trial on the effect of low-dose radiotherapy for painful osteoarthritis-final results after 12-month follow-up.
Marcus Niewald, Sobhan Moumeniahangar, Lara N Müller, Matthias G Hautmann, Yvonne Dzierma, Jochen Fleckenstein

Strahlenther Onkol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Prevention, Diagnosis, Therapy, and Follow-up of Lung Cancer - Interdisciplinary Guideline of the German Respiratory Society and the German Cancer Society - Abridged Version].
Wolfgang Schütte, Sylvia Gütz, Wiebke Nehls, Torsten Gerriet Blum, Wolfgang Brückl, Jochen Fleckenstein

Pneumologie· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation and Dose-densification of R-CHOP in Primary Mediastinal B-cell Lymphoma: Subgroup Analysis of the UNFOLDER Trial.
Gerhard Held, Lorenz Thurner, Viola Poeschel, German Ott, Christian Schmidt, Jochen Fleckenstein

Hemasphere· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER Study.
Lorenz Thurner, Marita Ziepert, Christian Berdel, Christian Schmidt, Peter Borchmann, Jochen Fleckenstein

Hemasphere· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Training of radiotherapy professionals: status, content, satisfaction and improvement suggestions in the Greater Region.
Nadège Dubois, Anh Nguyet Diep, Alexandre Ghuysen, Joséfine Declaye, Anne-Françoise Donneau, Jochen Fleckenstein

BMC Med Educ· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and clinical usefulness of modelling glioblastoma migration in adjuvant radiotherapy.
Sven Knobe, Yvonne Dzierma, Michael Wenske, Christian Berdel, Jochen Fleckenstein

Z Med Phys· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ArthroRad trial: multicentric prospective and randomized single-blinded trial on the effect of low-dose radiotherapy for painful osteoarthritis depending on the dose-results after 3 months' follow-up.
Marcus Niewald, Lara Natalie Müller, Matthias G Hautmann, Yvonne Dzierma, Patrick Melchior, Jochen Fleckenstein

Strahlenther Onkol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of radiotherapy protocol adherence in NSCLC patients treated with concurrent chemoradiation: RTQA results of the PET-Plan trial.
Eleni Gkika, Tanja Schimek-Jasch, Stephanie Kremp, Stefan Lenz, Marcus Stockinger, Jochen Fleckenstein

Radiother Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Diffusion-weighted MRI improves response assessment after definitive radiotherapy in patients with NSCLC.
Philippe Jagoda, Jochen Fleckenstein, Mathias Sonnhoff, Günther Schneider, Christian Ruebe

Cancer Imaging· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffusion-weighted MRI improves response assessment after definitive radiotherapy in patients with NSCLC.
Philippe Jagoda, Jochen Fleckenstein, Mathias Sonnhoff, Günther Schneider, Christian Ruebe

Cancer Imaging· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Toxicity of Different Chemotherapy Protocols for Concurrent Chemoradiation in Non-Small Cell Lung Cancer-A Secondary Analysis of the PET Plan Trial.
Eleni Gkika, Stefan Lenz, Tanja Schimek-Jasch, Cornelius F Waller, Stephanie Kremp, Jochen Fleckenstein

Cancers (Basel)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of DNA damage by 53PB1 and pKu70 detection in peripheral blood lymphocytes by immunofluorescence and high-resolution transmission electron microscopy.
Yvonne Lorat, Jochen Fleckenstein, Patric Görlinger, Christian Rübe, Claudia E Rübe

Strahlenther Onkol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial.
Ursula Nestle, Tanja Schimek-Jasch, Stephanie Kremp, Andrea Schaefer-Schuler, Michael Mix, Jochen Fleckenstein

Lancet Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NHL-ChirEx: An interprofessional cross-border education initiative in the Greater Region with a focus on radiation morbidity and patient safety.
Guillaume Vogin, Jochen Fleckenstein, Jean-Christophe Servotte, Philippe Nickers, Anne Ebersberger

Radiother Oncol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Diffusion-Weighted MRI on the Definition of Gross Tumor Volume in Radiotherapy of Non-Small-Cell Lung Cancer.
Jochen Fleckenstein, Michael Jelden, Stephanie Kremp, Philippe Jagoda, Jonas Stroeder

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy of painful heel spur with two fractionation regimens : Results of a randomized multicenter trial after 48 weeks' follow-up.
Benjamin Prokein, Henrik Holtmann, Matthias G Hautmann, Hans-Peter Rösler, Stefan Graeber, Jochen Fleckenstein

Strahlenther Onkol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mARC Treatment of Hypopharynx Carcinoma with Flat and Flattening-Filter-Free Beam Energies - A Planning Study.
Katharina Bell, Jochen Fleckenstein, Frank Nuesken, Norbert Licht, Christian Rübe

PLoS One· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective analysis of stereotactic ablative radiotherapy (SABR) for metastatic lung lesions (MLLs) in comparison with a contemporaneous cohort of primary lung lesions (PLLs).
Feras Oskan, Yvonne Dzierma, Stefan Wagenpfeil, Christian Rübe, Jochen Fleckenstein

J Thorac Dis· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
Jochen Fleckenstein, Alev Petroff, Hans-Joachim Schäfers, Thomas Wehler, Jakob Schöpe

BMC Cancer· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IMRT and 3D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC: A direct comparison of PET-based treatment planning.
Jochen Fleckenstein, Katharina Kremp, Stephanie Kremp, Jan Palm, Christian Rübe

Strahlenther Onkol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VMAT to arclet plan conversion in a treatment planning system : Feasibility and dosimetric relationship between VMAT, arclet, and stationary fields.
Yvonne Dzierma, Norbert Licht, Ian Norton, Frank Nuesken, Christian Rübe, Jochen Fleckenstein

Strahlenther Onkol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis